id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-E-1435-0007,FDA,FDA-2013-E-1435,Notice of Final Determination Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T13:27:17Z,,0,0,090000648243a249
FDA-2013-E-1435-0006,FDA,FDA-2013-E-1435,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-08-02T04:00:00Z,2016,8,2016-08-02T04:00:00Z,,2016-08-03T00:45:39Z,,0,0,090000648214fce2
FDA-2013-E-1435-0005,FDA,FDA-2013-E-1435,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2015-12-28T05:00:00Z,2015,12,2015-12-28T05:00:00Z,,2015-12-29T02:21:39Z,,0,0,0900006481dd65ae
FDA-2013-E-1435-0004,FDA,FDA-2013-E-1435,"Determination of Regulatory Review Period for Purposes of Patent Extension: JETREA,",Notice,Determinations,2015-12-23T05:00:00Z,2015,12,2015-12-23T05:00:00Z,2016-02-23T04:59:59Z,2015-12-23T17:24:27Z,2015-32247,0,0,0900006481dcaddc
FDA-2013-E-1435-0003,FDA,FDA-2013-E-1435,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2014-01-31T05:00:00Z,2014,1,2014-01-31T05:00:00Z,,2014-01-31T16:16:25Z,,0,0,0900006481539857
FDA-2013-E-1435-0002,FDA,FDA-2013-E-1435,ThromboGenics NV (Fish & Richardson) - Patent Extension Application,Other,Application,2013-11-14T05:00:00Z,2013,11,2013-11-14T05:00:00Z,,2013-11-14T20:15:22Z,,0,0,090000648147ee9a
FDA-2013-E-1435-0001,FDA,FDA-2013-E-1435,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-11-14T05:00:00Z,2013,11,2013-11-14T05:00:00Z,,2013-11-14T20:15:22Z,,0,0,090000648147ee4a